Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion–Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations

Title
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion–Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations
Authors
Keywords
EGFR, mutation, EML4-ALK, fusion, KRAS, mutation, pemetrexed-based therapy, ROS1, fusion
Journal
Journal of Thoracic Oncology
Volume 11, Issue 7, Pages 1140-1152
Publisher
Elsevier BV
Online
2016-04-18
DOI
10.1016/j.jtho.2016.03.022

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now